Skip to main content

Resmed Inc (RMD)

Sector
Health Care
Industry
Health Care Equipment
Last price
$235.30
As of

Kresmion compiles this page from RMD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

RESMED INC (RMD): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-30.

As of . Source: SEC EDGAR filings for RMD. Method and limitations.

COMPANY DOSSIER

See the full RMD dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for RMD on one page. Preview it with sample data, then open it live with a free account.

Preview the RMD dossier

Active events for RMD

FREE, NO ACCOUNT

Every event on RMD, as it fires

You are seeing 5 of 15 events recorded on RMD since 2026-05-16.

The five above landed across 3 days. The other 10 were recorded on 2 other days. 13 of the 15 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

RMD positions held by the managers we follow (2026Q2)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
CITADEL ADVISORS LLC FundCUSIP 761152107 · 2026Q2$99.1M0.06%
TWO SIGMA INVESTMENTS, LP FundCUSIP 761152107 · 2026Q2$80.1M0.06%
MILLENNIUM MANAGEMENT LLC FundCUSIP 761152107 · 2026Q2$39.9M0.03%
Bridgewater Associates, LP FundCUSIP 761152107 · 2026Q2$13.1M0.05%
D. E. Shaw & Co., Inc. FundCUSIP 761152107 · 2026Q2$1.2M0.00%
RENAISSANCE TECHNOLOGIES LLC FundCUSIP 761152107 · 2026Q2$316K0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, RMD

More data on RMD

RMD against its peers

RMD's operating margin of 33.4% ranks in the 97th percentile of 14 Health Care Equipment sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-06-30.

MetricRMDPeer medianPercentilen
Revenue FY5.7B USD9.1B USD3014
Revenue YoY9.9%n/an/a1
Gross margin61.1%64.0%3913
Operating margin33.4%18.1%9714
Net margin26.9%13.2%9014
Return on equity23.1%12.2%8314
P / E22.6x38.0x1813
1 year-5.7%4.0%3714

Peers (14): DXCM, GEHC, STE, IDXX, ZBH, EW, BSX, RVTY, BAX, PODD, SYK, MDT, ISRG, ABT. Left out: BDX (no annual filing). Fiscal periods ending between 2025-12-28 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (RMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in RMD on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on RMD in the last 180 days.

Upstream: SEC EDGAR filings for RMD

Kresmion, "RESMED INC (RMD) institutional holdings and SEC filings", data as of 2026-11-01, https://kresmion.com/research/RMD. Upstream data: SEC EDGAR filings for RMD.

Link to this data (HTML):

<a href="https://kresmion.com/research/RMD">RESMED INC (RMD) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow RMD on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to RMD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the RMD dossier
Share

The RMD intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.